Search research articles
Contact Us
Filters
Showing results (271-280 of 478) with videos related to
Page
of 48
Sort By:
Blut
|
April 1, 1980
Post-transfusion thrombocytopenic purpura: immunological and clinical studies in two cases and review of the literature
C Mueller-Eckhardt, K Lechner, D Heinrich, et al.
Thrombosis and Haemostasis
|
December 1, 1994
Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo
S Eichinger, M Wolz, M Nieszpaur-Los, et al.
British Journal of Haematology
|
February 1, 1989
Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-PlA1 specificity: evidence for a host-derived immune reaction
S Panzer, V Kiefel, C R Bartram, et al.
Leukemia & Lymphoma
|
August 23, 2000
Generation of dendritic cells from human chronic myelomonocytic leukemia cells in fetal calf serum-free medium
L Oehler, A Berer, F Keil, et al.
Annals of Hematology
|
June 28, 2000
Effect of interleukin-3, stem cell factor and granulocyte-macrophage colony-stimulating factor on committed stem cells, long-term culture initiating cells and bone marrow stroma in a one-step long-term bone marrow culture
F Keil, X Chen, N Louda, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
MRP expression in acute myeloid leukemia. An update
M Filipits, T Stranzl, G Pohl, et al.
European Journal of Haematology
|
December 12, 2001
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation
C Rintelen, I Pabinger, P Bettelheim, et al.
Bone Marrow Transplantation
|
January 1, 1991
Prevention of early interstitial pneumonitis (IP) after BMT by exclusion of CMV-IG-POS platelet donors, prophylaxis with CMV immune globuline, and by a modified TBI regimen
W Hinterberger, G Alth, P Höcker, et al.
The Journal of Pediatrics
|
February 5, 1999
Clinical significance of lupus anticoagulants in children
C Male, K Lechner, S Eichinger, et al.
Critical Care Medicine
|
April 1, 1994
Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin
S Kapiotis, P Quehenberger, H G Eichler, et al.
Page
of 48
Search research articles
Search
Showing results (271-280 of 478) with videos related to
Sort By:
Page
of 48
Blut
|
April 1, 1980
Post-transfusion thrombocytopenic purpura: immunological and clinical studies in two cases and review of the literature
C Mueller-Eckhardt, K Lechner, D Heinrich, et al.
Thrombosis and Haemostasis
|
December 1, 1994
Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo
S Eichinger, M Wolz, M Nieszpaur-Los, et al.
British Journal of Haematology
|
February 1, 1989
Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-PlA1 specificity: evidence for a host-derived immune reaction
S Panzer, V Kiefel, C R Bartram, et al.
Leukemia & Lymphoma
|
August 23, 2000
Generation of dendritic cells from human chronic myelomonocytic leukemia cells in fetal calf serum-free medium
L Oehler, A Berer, F Keil, et al.
Annals of Hematology
|
June 28, 2000
Effect of interleukin-3, stem cell factor and granulocyte-macrophage colony-stimulating factor on committed stem cells, long-term culture initiating cells and bone marrow stroma in a one-step long-term bone marrow culture
F Keil, X Chen, N Louda, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
MRP expression in acute myeloid leukemia. An update
M Filipits, T Stranzl, G Pohl, et al.
European Journal of Haematology
|
December 12, 2001
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation
C Rintelen, I Pabinger, P Bettelheim, et al.
Bone Marrow Transplantation
|
January 1, 1991
Prevention of early interstitial pneumonitis (IP) after BMT by exclusion of CMV-IG-POS platelet donors, prophylaxis with CMV immune globuline, and by a modified TBI regimen
W Hinterberger, G Alth, P Höcker, et al.
The Journal of Pediatrics
|
February 5, 1999
Clinical significance of lupus anticoagulants in children
C Male, K Lechner, S Eichinger, et al.
Critical Care Medicine
|
April 1, 1994
Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin
S Kapiotis, P Quehenberger, H G Eichler, et al.
Page
of 48